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LmrP, a proton/multidrug antiporter of Lactococcus lactis, transports a variety of cationic substrates. Previously, two membrane-
embedded acidic residues, Asp142 and Glu327, have been reported to be important for multidrug transport activity of LmrP. Here we show that
neither Glu327 nor Asp142 is essential for ethidium binding but that Glu327 is a critical residue for the high affinity binding of Hoechst 33342.
Substitution of these two residues, however, negatively influences the transport activity. The energetics of transport was studied of two
closely related cationic substrates ethidium and propidium that carry one and two positive charges, respectively. Extrusion of monovalent
ethidium is dependent on both the electrical membrane potential (Dw) and transmembrane proton gradient (DpH), while extrusion of
propidium predominantly depends on the DpH only. The LmrP mutants D142C and E327C, however, mediate electroneutral ethidium
extrusion, but are unable to mediate DpH-dependent extrusion of propidium. These data indicate that Asp142 and Glu327 are involved in
proton translocation.
D 2004 Elsevier B.V. All rights reserved.Keywords: Energetics; LmrP; Lactococcus lactis1. Introduction
Microorganisms are, in their natural environments,
continuously exposed to a variety of toxic compounds from
natural and/or industrial sources. To survive the poisonous
effects of these cytotoxic compounds, several defense
mechanisms have been developed. One of these defense
mechanisms is the active extrusion of cytotoxic compounds
from the cell by drug efflux transporters present in the0005-2728/$ - see front matter D 2004 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbabio.2004.06.004
Abbreviations: MDR, multidrug resistance; pmf, proton motive force;
TPP+, tetraphenylphosphonium; TMA-DPH, 1-(4-trimethylammonium-
phenyl)-6-phenyl-1,3,5-hexatriene p-toluenesulfonate; His6-tag, six-histi-
dine tag; DDM, dodecyl-h-maltoside
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strong Road, London SW7 2AZ, United Kingdom.cytoplasmic membrane. Besides the specific drug efflux
systems (SDRs), multidrug resistance (MDR) transporters
are found, which can extrude a wide variety of structurally
unrelated compounds. The energy for the efflux process by
MDR transporters can be supplied directly by either (i) a
proton or sodium motive force (pmf or smf) in secondary
MDRs or (ii) ATP in ATP-binding cassette (ABC)-MDR
transporters [1].
One of the MDR extrusion systems of Lactococcus lactis
is the proton motive force-driven secondary transporter
LmrP. It is a 408-amino-acid protein with 12 putative
transmembrane helices, which contains motifs diagnostic for
the Major Facilitator Superfamily of the secondary trans-
porters [2]. LmrP has a very broad substrate specificity and
extrudes a variety of lipophilic cationic compounds such as
ethidium, daunomycin, tetraphenylphosphonium (TPP+)
and Hoechst 33342 [2–4]. It also confers resistance to
several broad-spectrum antibiotics [5]. LmrP can mediate
DpH- and Dw-driven extrusion of monovalent cations suchta 1658 (2004) 252–261
Fig. 1. Chemical structures of ethidium and propidium. Both compounds
contain quaternary ammonium which gives them one and two positive
charges, respectively.
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lammoniumphenyl)-6-phenyl-1,3,5-hexatriene p-toluenesul-
fonate (TMA-DPH) from cells or right-side-out membrane
vesicles and the uptake of these compounds in inside-out
membrane vesicles [3]. These observations indicate that
LmrP catalyzes electrogenic H+/drug antiport in which at
least two protons are exchanged for one drug molecule.
Extensive studies have been focused on the cellular
compartment from which LmrP picks up its highly lip-
ophilic substrates [3]. In these studies the compound TMA-
DPH was used, a probe that is fluorescent only in the
hydrophobic environment of the membrane. The activity of
LmrP was found to depend on the concentration of TMA-
DPH in the inner leaflet of the lipid bilayer. These and other
data provided convincing evidence that LmrP functions as a
vacuum-cleaner catalyzing drug efflux from the inner leaflet
of the membrane directly into the external medium [6].
Substrate competition experiments [7] revealed that LmrP-
mediated Hoechst 33342 efflux is competitively inhibited
by quinine and verapamil, noncompetitively by nicardipin
and vinblastin, and uncompetitively by TPP+. These
findings indicate the presence of multiple drug binding sites
in the multidrug transporter LmrP. The presence of multiple
drug binding sites in MDR transporters was later also
demonstrated for the Major Facilitator Superfamily H+/drug
antiporter MdfA of Escherichia coli [8].
LmrP-mediated efflux of cationic drugs from the inner
leaflet of the membrane predicts an electrostatic interaction
of the substrates with acidic residues, especially those
located in the transmembrane domains of LmrP. Cysteine
scanning mutagenesis of LmrP in combination with thiol
chemistry identified three membrane-embedded acidic
residues: Asp142, Glu327 and Glu388 [9]. The role of these
residues in drug recognition was evaluated in transport
experiments with the cationic substrates ethidium and
Hoechst 33342 with wild-type (WT) and mutant LmrPs in
which each of these residues had been replaced by cysteine,
alanine, lysine, glutamate or aspartate. These studies
revealed an important but not crucial role of the negative
charges at positions 142 and 327 in the transport process by
LmrP [9].
To elucidate further the role of Asp142 and Glu327 in
substrate binding and transport, direct substrate binding
studies were performed with purified WT and mutant
LmrPs. Furthermore, the role of the proton motive force
(pmf) and its components, the DpH and the Dw, in driving
the extrusion of differently charged substrates was evaluated
(chemical structures of the substrates are shown in Fig. 1).
The results indicate that Glu327, but not Asp142, is an
essential residue for the high affinity binding of Hoechst
33342. WT LmrP was found to mediate electrogenic
transport of ethidium, consistent with a previous report in
which other monovalent substrates of LmrP were studied
[3]. In contrast, LmrP-mediated transport of propidium, a
compound which carries two positive charges, depends
mainly upon the DpH. The LmrP mutants D142C andE327C mediate transport of ethidium in a Dw-independent
manner, suggesting a direct role of these two residues in
proton translocation.2. Experimental procedures
2.1. Bacterial strains, plasmids, and growth conditions
L. lactis NZ9000 (DlmrA) [10], which lacks the gene
encoding the ATP-binding cassette-type MDR transporter
LmrA, was used in combination with the nisin controlled
expression (NICE) system [11,12] for overexpression of
WT and mutant LmrP proteins [4,9]. L. lactis was grown
at 30 8C in M17 medium (Difco) supplemented with 0.5%
(w/v) glucose and 5 Ag/ml chloramphenicol. Expression of
LmrP variants from pNZ8048-derived plasmids was
induced by adding approximately 10 ng nisin A/ml at an
A660 of about 0.6, and cells were harvested 60 min after
induction.
2.2. Recombinant DNA techniques
General procedures for cloning and DNA manipulation
were performed essentially as described by Sambrook et al.
[13]. The PCR overlap extension method [14] was used to
introduce the D142C mutation in the lmrP gene on the
pHLP5 expression plasmid [4], which encodes LmrP with a
C-terminal six-histidine tag (His6-tag). The PCR-amplified
DNA fragment was sequenced to verify that only the
intended changes were introduced. DNA sequencing was
performed at the BioMedical Technology Centre (University
of Groningen, Groningen, The Netherlands).
2.3. Expression levels of proteins
Expression levels of His6-tagged proteins were deter-
mined by SDS polyacrylamide gel analysis of membrane
vesicles or sonicated cells (20 Ag of total protein), followed
by transfer to polyvinylidene difluoride membranes, and
immunodetection using monoclonal antibodies directed
against the His6-tag (Dianova, Hamburg, Germany). Anti-
bodies were visualized by the Western-light chemilumines-
cence detection kit (Tropix, Bedford, MA, USA) using a
Lumi-Imager F1 (Roche).
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Inside-out membrane vesicles were prepared from L.
lactis NZ9000 (DlmrA) cells expressing LmrP variants by
French press treatment [4]. Membranes were frozen in
liquid nitrogen and stored at 80 8C at a protein
concentration of 15 to 35 mg/ml in 10 mM K-HEPES, pH
7.0, containing 50 mM K2SO4, 5 mM MgSO4, 8 mM NaCl
and 10% (w/v) glycerol.
2.5. Binding of Hoechst 33342
Binding of Hoechst 33342 to LmrP was quantified using
the enhancement of Hoechst 33342 fluorescence upon
binding to the protein, essentially as described previously
by Qu and Sharom [15] and Qu et al. [16]. His6-tagged
LmrP was purified on Ni-NTA agarose as described
elsewhere [4]. The protein was eluted with 50 mM
potassium phosphate pH 7.0, containing 250 mM imidazole,
100 mM NaCl and 0.05% dodecyl-h-maltoside (DDM).
Elution fractions containing mainly LmrP were concentrated
on a MicroconR centrifugal filter device (Millipore Corpo-
ration, Bedford, MA, USA) with the nominal molecular
weight limit of 30 kDa. The concentration step was
followed by two washing steps with the binding buffer
(50 mM Tris–Cl pH 7.0 containing 100 mM NaCl and
0.05% DDM). The LmrP concentration in all binding
experiments was 25 Ag/ml. The increase of Hoechst
33342 fluorescence during titration was recorded at 20 8C
with a Perkin-Elmer LS 50B fluorimeter, using excitation
and emission wavelengths of 355 and 457 nm, respectively,
and slit widths of 2.5 nm each. To correct the fluorescence
enhancement data, the following equation was used:
Fcorr ¼ Fi  Bið Þ Vi=V0ð Þ  100:5b AEexþAEemð Þ ð1Þ
where Fcorr is the corrected value of the fluorescence
intensity, Fi the experimentally measured fluorescence
intensity, Bi the fluorescence intensity of free Hoechst
33342 in the binding buffer, V0 the initial volume of the
sample, Vi the volume of the sample at a given point of
titration, b the optical path length of the cuvette in
centimeters, and AEex and AEem the absorbance of the
sample at the excitation and emission wavelengths, respec-
tively. To estimate the Kd values for Hoechst 33342 binding
to LmrP, the obtained data were fitted to the equation:
DF ¼ DFmax H½ = Kd þ H½ ð Þ ð2Þ
where DF is the increase in fluorescence relative to the
initial value after addition of Hoechst 33342 at a concen-
tration [H], and DFmax the maximum enhancement in
fluorescence intensity that occurs upon saturation of the
substrate binding site.
Quinine titration data were corrected for the fluorescence
of Hoechst 33342 in the absence of LmrP. The concentration
of quinine which inhibits Hoechst 33342 binding by 50%(IC50) was calculated with Sigma Plot software (SPSS Inc.,
Chicago, IL, USA) using the following equation:
Fh ¼ Fmin þ Fmax  Fminð Þ= 1þ 10log I½ log IC50ð Þ
 
ð3Þ
where Fh is the measured Hoechst 33342 fluorescence in the
presence of various concentrations of quinine, Fmax the
maximal fluorescence in the absence of quinine, Fmin the
minimal fluorescence in the presence of saturating concen-
trations of quinine, and log[I] the logarithm of the quinine
concentration. The obtained IC50 value was used to
calculate Ki for quinine by using the equation of Cheng
and Prusoff [17]:
Ki ¼ IC50= 1þ H½ =Kdð Þ ð4Þ
where Kd is the apparent affinity of Hoechst 33342 for
LmrP.
2.6. Binding of ethidium
Ethidium binding was measured as described by Muth
and Schuldiner [18]. Membrane vesicles containing 30 mg
of total protein were solubilized as described [4]. The
supernatant obtained after ultracentrifugation was mixed
with 1.0 ml of equilibrated Ni-NTA agarose resin followed
by 45 min incubation at 48C. The unbound fraction was
removed by centrifugation for 10 s at the top speed of a
table centrifuge, and the resin was washed once with wash
buffer containing 20 mM imidazole. Washed resin with
bound LmrP (LmrP-resin) was resuspended in 50 mM
potassium phosphate pH 7.0 containing 100 mM NaCl and
0.05% DDM in a volume of 1 ml. LmrP-resin (100 Al) was
incubated at 48C with 400 Al of 50 mM potassium
phosphate pH 7.0, 100 mM NaCl and 0.05% DDM
containing 5 AM ethidium. As a negative control, 1 mM
quinine was added to inhibit ethidium binding. Binding
reactions were terminated by separating the beads from the
supernatant by centrifugation. The pellet resin fraction was
collected and incubated for 5 min at room temperature with
200 Al of 50 mM potassium phosphate pH 7.0 containing
100 mM NaCl, 0.05% DDM and 250 mM imidazole to
release the His6-tagged LmrP and ethidium from the resin.
After centrifugation, 150 Al of supernatant was used to
determine the amount of His6-tagged-LmrP-bound ethidium
by measuring fluorescence with a Perkin-Elmer LS 50B
fluorimeter, using excitation and emission wavelengths of
500 and 580 nm, respectively, and slit widths of 10 nm each.
All binding reactions were performed in triplicate. The
amount of LmrP bound to Ni-NTA agarose was determined
with the RC-DC protein assay kit from Bio-Rad (100 Ag of
LmrP per 100 Al of Ni-NTA suspension).
2.7. Ethidium and propidium transport
Ethidium transport experiments were performed as
reported previously [9,19]. Control cells harboring vector
Fig. 2. Overexpression of LmrP in cells (A) and inside out-membrane
vesicles (B) of L. lactis. Cells harboring an empty vector pNZ8048 and
plasmids encoding for the WT and mutants of LmrP were cultured as
described in Experimental procedures. Cells were sonicated and proteins
separated by SDS-PAGE. Membrane vesicles were prepared as described in
Experimental procedures. Each lane was loaded with 20 Ag of protein. His6-
tagged proteins were detected with monoclonal antibodies directed against
the tag.
Table 1
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vested by centrifugation, washed twice with 50 mM
potassium phosphate pH 7.0, containing 5 mM MgSO4,
and suspended in the same buffer to an A660 of 0.5.
Transport assays were performed at 30 8C. Cells (2 ml) were
pre-energized by the addition of 25 mM glucose. After 5
min, 10 AM ethidium was added to the cell suspension and
the accumulation of ethidium was measured indirectly by
following the fluorescence of the ethidium–polynucleotide
complex in the cells. Fluorescence was monitored with a
Perkin-Elmer LS 50B fluorimeter, using excitation and
emission wavelengths of 500 and 580 nm, respectively. To
determine the rate of passive ethidium influx into L. lactis
cells, ethidium transport assays were performed in the
absence of glucose. Propidium (Molecular Probes Inc.,
Eugene, OR, USA) transport assays were carried out with
10 AM propidium as described for ethidium.






WT 1.3F0.1 +++ +++
C270A 1.8F0.1 ++ ++
D142C-E327C-C270A 7.0F0.4  
D142A 1.2F0.3 /+ /+
D142C 0.4F0.06 ++ +
E327A 65.0# ++ 
E327C 12.8# ++ +
Kd values are an average from three measurements (for details see
Experimental procedures); F indicates standard errors. Kd values marked
with # are only an approximate estimation since the saturation of Hoechst3. Results
3.1. Construction and expression of D142C LmrP mutant
LmrP contains two negatively charged amino acids in its
membrane domain which are important for substrate trans-
port [9]. One of these residues Glu327 was replaced by
cysteine. This E327C2 mutant was found to transport
Hoechst 33342 at a lower rate than WT LmrP but at a
higher rate than the double mutant E327C-C270A in which
also the endogenous Cys270 was replaced by alanine [19].2 It should be noted that the annotation of the cysteine mutants used in
this manuscript differs from the annotation used in the Ref. [9] (E327C-
C270A was E327C; D142C-C270A was D142C).To evaluate also the role of the second critical negatively
charged residue Asp142, a single mutant D142C of LmrP
was constructed. Western blot analysis with anti-His6-tag
antibodies showed that the D142C mutant was expressed to
similar levels as WT and E327C LmrP (Fig. 2). The
transport activity of D142C LmrP was similar to the double
mutant D142C-C270A but lower than WT LmrP (see Fig. 4,
Table 1 and data not shown).
3.2. Hoechst 33342 binding to purified wild-type and
mutant LmrP
The fluorescent dye Hoechst 33342 is a well-studied
model substrate for LmrP as its transport can be measured
both in proteoliposomes reconstituted with purified LmrP
and in inside-out membrane vesicles of L. lactis over-
expressing LmrP [4]. Binding of Hoechst 33342 to WT and
mutant LmrP protein was determined with the method
developed by Qu et al. [16]. This method is based on the
enhancement of Hoechst 33342 fluorescence upon transfer
from a polar (aqueous) environment to a less polar binding
site on the protein. Titration of purified LmrP with Hoechst
33342 resulted in an increase of the dye fluorescence up to
saturation levels (see Fig. 3A and B). The experimental data
could be fitted with a binding equation for a single binding
site (see Eq. (2)) and yielded an apparent Kd value of 1.3
AM (Table 1). The specificity of Hoechst 33342 binding was
assessed by the addition of the competitive inhibitor quinine
to chase bound Hoechst 33342. The fluorescence of Hoechst
33342 bound to LmrP decreased with increasing concen-
trations of quinine (Fig. 3C). From the data obtained, an
apparent Ki of 3 AM of quinine could be estimated.
Subsequently, the binding was measured of Hoechst
33342 to the E327C and D142C LmrP mutants (Table 1).
The D142C LmrP mutant showed a similar Hoechst 33342
binding as WT LmrP, with an estimated Kd value of 0.4 AM.
Likewise, a similar result was obtained with the D142A33342 binding was not reached. Transport activities were measured in L.
lactis cells, expressing WT or mutant LmrP, with glucose as energy source.
The transport activities with the exception of these for the D142C mutant
come from Refs. [9] and [19]. (+++) stands for the WT activity, and () for
the lack of the transport activity.
Fig. 4. Ethidium binding by WT and mutants of LmrP. Purified and
immobilized on Ni-NTA agarose His6-tagged LmrP variants were incubated
in a buffer containing 5 AM ethidium or 5 AM ethidium and 1 mM quinine.
Ethidium retained by the resin and resin-bound LmrP was assayed
fluorimetrically as described in Experimental procedures. Ethidium binding
to resin loaded with WT LmrP is taken as 100%.
Fig. 3. Purified LmrP binds specifically Hoechst 33342. (A) An example of
raw data of enhancement of Hoechst 33342 fluorescence upon binding to
LmrP ( F i, open circles) and Hoechst 33342 fluorescence in the buffer (Bi,
closed circles); A.U., arbitrary units. LmrP solutions (25 Ag/ml protein)
were titrated with increasing concentrations of Hoechst 33342 at 20 8C. (B)
Hoechst 33342 binding to WT LmrP. The data are corrected for
fluorescence of free Hoechst in the buffer, light scattering, and inner filters
effects according to Eq. (1). The curve was obtained by fitting the data
points to Eq. (2). The data points are an average from three measurements.
(C) Inhibition of Hoechst 33342 binding to LmrP by quinine. LmrP
solutions (25 Ag/ml protein) containing 1 AM Hoechst 33342 were titrated
with increasing concentrations of quinine. The curve was obtained by
fitting the data points to Eq. (3). The data points are the average of two
experiments.
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had a drastically reduced binding affinity of Hoechst 33342.
Since saturation of Hoechst 33342 binding could not be
reached, the Kd values could only be roughly estimated
(Table 1). These observations clearly demonstrate that
Glu327 is a critical residue for the high affinity binding of
Hoechst 33342.3.3. Binding of ethidium to LmrP
To measure the binding of ethidium to LmrP, the method
developed by Muth and Schuldiner [18] was used. WT and
mutants of LmrP were purified and immobilized on Ni-NTA
agarose. Immobilized LmrP was incubated with 5 AM
ethidium, and Ni-NTA-LmrP with bound ethidium was
collected by centrifugation. LmrP with bound ethidium was
released from the resin by imidazole and the fluorescence of
ethidium in the eluate was measured (see Experimental
procedures). Ethidium was found to bind specifically to
immobilized WT LmrP, and this binding was significantly
inhibited by a 200-fold excess of quinine (Fig. 4).
Surprisingly, ethidium binding by immobilized D142C
and E327C LmrP was only slightly lower than observed
for WT LmrP (Fig. 4). This suggests that neither Asp142 nor
Glu327 is critical for binding of ethidium at the concentration
(10 AM) used in transport studies.
3.4. Transport of ethidium
Accumulation of ethidium in cells can be measured
fluorimetrically by following in time the changes of the
fluorescence of the intracellular ethidium-polynucleotide
complex [4,9,19,20]. Under non-energized conditions, L.
lactis not expressing LmrP (i.e., control cells) slowly
accumulate ethidium (Fig. 5A, solid line). In contrast, a
rapid influx of ethidium occurred in WT LmrP-expressing
cells (Fig. 5B, solid line). This ethidium influx is LmrP-
mediated [19]. Cells expressing the E327C or D142C LmrP
mutants (Fig. 5C and D, solid lines) showed only moderate
rates of ethidium influx under non-energized conditions,
although significantly above the rate of ethidium influx into
control cells (see also Table 1).
Upon addition of glucose, L. lactis cells generate a pmf
by proton pumping coupled to ATP hydrolysis by the
Fig. 5. Ethidium accumulation under different energetic conditions by L. lactis cells expressing WT or mutant LmrP. (A) Control cells not expressing LmrP; (B)
WT LmrP-expressing cells; (C) D142C mutant LmrP-expressing cells; (D) E327C mutant LmrP-expressing cells. Et indicates addition of 10 AM ethidium.
Solid lines represent traces obtained under non-energized conditions. Energized conditions: dashed lines, valinomycin was added at time point (1) and nigericin
at time point (2); dotted lines, nigericin was added at time point (1) and valinomycin at time point (2). Valinomycin and nigericin were added to final
concentrations of 2 AM. A.U., arbitrary units. For details see Experimental procedures.
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pmf, the membrane potential (Dw) and the proton gradient
(DpH), can be dissipated by the ionophores valinomycin and
nigericin, respectively. 2-Aminobutyric acid is a non-
metabolisable analogue of alanine, which has been shown
to be transported in symport with protons. Both components
of the pmf, the Dw and the DpH, function as driving forces
for its transport [21,22]. The generation of a Dw and a DpH
upon glucose addition to WT and E327C or D142C LmrP
mutant overexpressing cells of L. lactis was demonstrated
by the effects of valinomycin and nigericin on the pmf-
driven uptake of 2-aminobutyric acid (data not shown). The
effects of these ionophores on 2-aminobutyric acid transport
were compared with pmf-driven transport of monovalent,
positively charged ethidium in cells of L. lactis. Glucose-
energized control cells accumulated ethidium at a signifi-
cantly higher rate than non-energized cells (Fig. 5A).
Dissipation of the Dw by valinomycin reduced the
accumulation of ethidium, while subsequent dissipation of
the DpH by nigericin did not further affect the ethidium
uptake. These results are in agreement with previous
suggestions that Dw (inside negative) drives passive
diffusion of lipophilic cationic compounds across the
membrane [19,23,24]. L. lactis cells overexpressing WT
LmrP accumulated under energized conditions significantly
less ethidium than control cells (Fig. 5A and B). Dissipation
of the Dw inhibited the efflux process and resulted in an
increased rate and extent of ethidium accumulation. Sub-
sequent dissipation of the DpH completely inhibited efflux
resulting in an increased ethidium influx rate and uptakelevel similar to the non-energized cells (Fig. 5B). Similarly,
a partial inhibition of ethidium efflux was obtained when
only the DpH was dissipated, and ethidium accumulation
level was further increased by the subsequent dissipation of
the Dw (Fig. 5B, dashed and dotted lines). Taken together,
these results demonstrate that ethidium efflux by WT LmrP
is driven by both Dw and DpH.
The effect of the ionophores was also determined on
pmf-driven ethidium efflux from L. lactis cells expressing
the D142C or E327C LmrP protein. In the presence of
glucose, the LmrP mutant cells (Fig. 5C and D, dashed
lines) accumulated ethidium to a higher level than cells
expressing WT LmrP (Fig. 5B), but significantly lower than
energized control cells (Fig. 5A). This demonstrates that
both mutants catalyzed ethidium efflux at a lower rate then
WT LmrP-expressing cells, despite their ability to bind
ethidium. Dissipation of the Dw hardly affected the
ethidium efflux activity, while subsequent dissipation of
the DpH completely abolished efflux (Fig. 5C and D,
dashed lines). A similar result was obtained when the DpH
was first dissipated, whereas subsequent dissipation of the
Dw had no further effect (Fig. 5C and D, dotted lines).
These observations suggest that ethidium efflux by the
D142C and E327C mutant LmrP proteins is driven mainly
by the DpH and hardly or not at all by the Dw.
3.5. Transport of propidium
Propidium, a fluorescent DNA/RNA stain, is structurally
similar to ethidium (Fig. 1) but carries two positive charges
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ethidium [25]. In the absence of a pmf, LmrP facilitates
diffusion of substrates in the direction dictated by the
substrate concentration gradient [19]. The transport of
propidium can be followed by measuring the fluorescence
of the transporting cells. To test if propidium is a substrate
of LmrP, the diffusion of propidium into non-energized
control and LmrP-overexpressing cells was monitored. Non-Fig. 6. Propidium accumulation under different energetic conditions by
cells of L. lactis. Propidium was added to the cell suspension of A660=0.5 at
the time point (a) to a final concentration of 10 AM. (A) Passive influx of
propidium into non-energized control (vector, solid line) and LmrP-
expressing cells (dotted line). Quinine (0.5 mM) was used to block
LmrP-facilitated diffusion of propidium (dashed line). DDM (0.1%) was
added to permeabilize the cell membrane (DDM). (B) Accumulation of
propidium by cells pre-energized with 25 mM glucose. Solid line, cells with
empty vector pNZ8048, (b) addition of valinomycin, (c) addition of
nigericin; dotted line and dashed line, cells expressing WT LmrP. For the
dotted line, (b) addition of valinomycin, (c) addition of nigericin; for the
dashed line, (b) addition of nigericin, (c) addition of valinomycin. (C)
Transport activity of LmrP mutants D142C (dotted line) and E327C
(dashed line) relative to cells harboring empty vector (solid line), (b)
addition of valinomycin, (c) addition of nigericin. Both ionophores were
added to final concentrations of 2 AM. A.U., arbitrary units.energized control cells accumulated propidium very slowly
(Fig. 6A, solid line), consistent with an efficient barrier
function of the cell membrane of L. lactis. Upon solubiliza-
tion of the cell membrane by addition of the detergent
dodecyl-h-maltoside (DDM), a rapid increase of the
propidium fluorescence occurred (Fig. 6A). In contrast,
LmrP-overexpressing non-energized cells took up propi-
dium very rapidly and the uptake was only slightly
stimulated by the subsequent addition of the detergent
(Fig. 6A, dotted line). This fast increase of propidium
uptake by LmrP overexpressing cells could be inhibited by
quinine (0.5 mM), an inhibitor of LmrP, [7], added prior to
propidium (Fig. 6A, dashed line). These results demonstrate
that propidium is a substrate of LmrP.
The impact of dissipating the Dw and/or the DpH on the
propidium fluxes into L. lactis cells was investigated is the
same way as for ethidium. Under energized conditions,
control cells accumulated propidium at a rate similar or
slightly higher than non-energized cells while dissipation of
the Dw and/or the DpH did not affect the rate of propidium
accumulation (Fig. 6B, solid line). Strikingly, energized
cells overexpressing LmrP accumulated propidium during
the first 40 s at a significantly higher rate than control cells
(Fig. 6B, dotted line) but the steady-state level of
accumulation was significantly lower than in non-energized
LmrP-overexpressing cells (Fig. 6A, dotted line). Unlike the
accumulation of ethidium, the uptake of propidium was only
slightly reduced upon the dissipation of the Dw while
subsequent dissipation of the DpH triggered a fast influx of
propidium to levels similar to those observed under non-
energized conditions (Fig. 6B, dotted line). When the DpH
was dissipated first, a fast development of propidium
fluorescence was observed, which was further stimulated
by addition of valinomycin (Fig. 6B, dashed line). Cells
expressing the D142C and E327C LmrP mutants behaved
essentially as control cells and showed hardly any propi-
dium efflux activities (Fig. 6C).4. Discussion
LmrP is a secondary MDR transporter that mediates the
extrusion of lipophilic drugs in exchanges for protons. In a
previous report, three membrane-embedded carboxylic
residues were identified with a critical role in the transport
mechanism [9]. Two of these residues, i.e., Asp142 and
Glu327, are important for the LmrP transport activity [9], but
their exact role in the transport process has remained
obscure. To obtain insight into the role of these residues,
substrate binding, transport and the energetics of drug
extrusion were analyzed for the side-directed LmrP mutants
at positions Asp142 and Glu327 and compared with WT
LmrP. For these experiments, transport of two cationic
substrates that differ in the number of positive charges, i.e.,
ethidium with one, and propidium with two positive
charges, was analyzed (Fig. 1).
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about 1.3 AM (Table 1). Hoechst 33342 binding could
competitively be inhibited by quinine (Fig. 3C), a known
inhibitor of LmrP-mediated Hoechst 33342 transport [7].
The measured Kd for Hoechst 33342 binding is close to the
apparent Km of 0.63 AM for LmrP-mediated Hoechst 33342
transport in inside-out membrane vesicles, while the Ki for
quinine (apparent Ki of 3.0 AM) is in the same range as the
IC50 of quinine of ~4.8 AM for Hoechst 33342 transport [7].
Substitution of Glu327 but not of Asp142 by alanine or
cysteine drastically reduced the affinity of LmrP for Hoechst
33342. Nevertheless, both the D142A and D142C LmrP
mutants were strongly impaired in Hoechst 33342 transport
[9]. As expected, also the triple mutant D142C-E327C-
C270A displayed a decreased affinity for Hoechst 33342
binding. This is most likely due to the E327C substitution,
since the mutations D142C and C270A have no effect on
Hoechst 33342 binding. This triple mutant is unable to
transport Hoechst 33342 although it still has affinity for
Hoechst 33342, suggesting that also hydrophobic interac-
tions play a role in Hoechst 33342 binding. Taken together,
these results indicate that Glu327, but not Asp142, plays a
crucial role in binding and transport of Hoechst 33342 to
LmrP. (Fig. 4). Both the D142C and E327C LmrP mutants
had reduced ethidium transport activity (Fig. 5C and D). At
the relatively high ethidium concentration (10 AM) used in
the transport assay, the negatively charged residues at
position 142 or 327 were found not to be essential for
ethidium binding. The strong decrease of transport activity
can thus not be explained by decreased binding. This
observation indicates that these two membrane-embedded
residues may not be involved in ethidium binding but may
play additional roles, possibly in proton translocation in the
transport process.
The substrates of LmrP used in this study can enter the
cells via passive diffusion and by LmrP-mediated facilitated
diffusion [19] and are excreted by pmf-driven active efflux
by LmrP. The driving force for passive diffusion across the
membrane of non-energized cells is the chemical gradient
of a substrate [26]. The rate of diffusion in non-energized
and energized control cells, lacking LmrP, is relatively high
for ethidium (Fig. 5A, solid line) but low for propidium
(Fig. 6A, solid line). In cells expressing LmrP, facilitated
influx driven by the chemical substrate gradient occurs via
LmrP in the absence of a pmf. The rate of facilitated influx
is high for ethidium (Fig. 5B, solid line) and propidium
(Fig. 6A, dotted line). In energized, LmrP-expressing cells,
the pmf will influence the distribution of the cationic
substrates in two ways: (i) the transmembrane potential
(inside negative) will stimulate passive influx across the
membrane [23,24,26], and (ii) the pmf will drive the active
extrusion. Due to this passive influx (leak), a continuous
action of the efflux system is required to keep the cells free
of the substrates. The relative roles of the Dw and the DpH
as driving forces for active extrusion will differ for the
differently charged substrates and will depend on the nettranslocation of charge and protons in the exchange
process. The Dw can only be a driving force for efflux if
the excreted cationic substrate has less charge than the
number of protons translocated per substrate molecule [26].
In growing cells of L. lactis suspended in medium of pH
7.0, the Dw component of the pmf is significantly higher
than the DpH component (ZDpH). Poolman et al. [27]
observed in such cells a Dw of about 55 mV and a
ZDpH of around 20 mV. The roles of these two
components of the pmf in LmrP-mediated transport of
ethidium and propidium were analyzed for WT LmrP and
mutants D142C and E327C. Since Hoechst 33342 can
undergo deprotonation, which also alters its fluorescence
intensity, the charge of the transported species is not
precisely defined under the experimental conditions. There-
fore, we could not use this substrate to investigate the role
of the Dw or DpH in energizing its transport. Transport of
ethidium by WT LmrP is partially inhibited by dissipation
of the Dw or pmf. Full inhibition is observed only upon
dissipation of the entire pmf. The remaining ethidium
transport activity in the presence of only the Dw (in
presence of nigericin) or the DpH (in presence of
valinomycin) can be explained by the concomitant increase
of one component upon the dissipation of the other
component of the pmf. As a result, the driving force for
the extrusion process will hardly change [22]. These results
are in agreement with an electrogenic nH+/substratez+
antiport mechanism previously proposed for substrates like
TPP+ and TMA-DPH [3]. This implies that at least two
protons (n=2) are translocated per molecule of a mono-
valent substrate (z=1). In contrast, transport of propidium
was not inhibited by the dissipation of the Dw alone, while
dissipation of the DpH alone resulted in very strong
inhibition of transport of this compound. Dissipation of
the Dw after dissipation of DpH had a small additional
inhibitory effect. These findings indicate that transport of
propidium, a substrate with two positive charges, is
predominantly driven by the DpH. Interestingly, within
the first 40 s after addition of propidium, the cells
expressing WT LmrP displayed under energized conditions
a faster influx rate than the control cells which are
essentially impermeable to propidium (Fig. 6B, dotted
and dashed lines). This rapid influx in the energized and
LmrP-expressing cells must, therefore, be LmrP-mediated.
The increased accumulation of propidium indicated that the
driving force for uptake, supplied by the chemical gradient
of propidium, exceeds in absolute value the outward
directed driving force supplied by the pmf. Summarizing,
these observations show that LmrP-mediated transport is
electrogenic for monovalent drugs and electroneutral for
divalent substrates. Lewinson et al. [28] also observed that
the electrogenicity of the transport reactions by for the E.
coli MDR transporter MdfA depended on the charge of the
substrate. MdfA mediates electrogenic transport of
uncharged substrates and electroneutral efflux of substrates
with a single positive charge.
Fig. 7. Proposed mechanism for transport by LmrP. The hydrophobic
binding pocket facing the membrane exposes deprotonated Asp142 (D) and
Glu327 (E) (I) which enables binding of a substrate (II); alternatively,
binding of substrates induces deprotonation of the indicated residues. When
occupied by the substrate, the binding site becomes accessible to the other
side of the membrane (III), whereupon binding of protons releases the
substrate. The protonated transporter returns to the inward facing
conformation, protons are released to the cytoplasm and a new cycle can
start. The proposed mechanism suggests that the pH will influence the
protonation state of Asp142 and Glu327 and, therefore, binding of substrates
should be pH-dependent.
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the D142C and E327C mutants revealed some interesting
differences. Despite similar levels of protein expression and
ethidium binding, the rates of facilitated ethidium influx via
these mutant LmrP proteins under non-energized conditions
were much slower than for WT LmrP. Apparently, the lack
of a negative charge at position 142 or 327 reduces the
transporter turnover. Under energized conditions, ethidium
transport mediated by the mutant LmrPs D142C and E327C
is Dw-independent. This strongly suggests that these
mutants catalyze electroneutral H+/ethidium exchange with
one-to-one stoichiometry. Both mutants showed a very low
propidium efflux activity and, therefore, the energetics of
transport of propidium was therefore not further analyzed.
The observations point towards a role of Asp142 or Glu327 in
proton translocation in the antiport process. Glu327 was also
found to be essential for high affinity binding of Hoechst
33342 but not of ethidium. Such a double role of Glu327
would be similar to the function of Glu14 in the transport
mechanism of EmrE [29–31]. E. coli EmrE is a member of
the Small Multidrug Resistance family, and Glu14 was
proposed to be an essential part of a binding domain shared
by substrates and protons but mutually exclusive in time
providing the molecular mechanism for the obligatory
exchange catalyzed by EmrE [29,31,32]. In this respect, it
would be interesting to evaluate the pH dependence of
Hoechst 33342 binding by D142C and E327C mutants.
Since our data indicate that only Glu327 is directly
interacting with Hoechst 33342, the D142C mutant should
display a more pronounced pH dependency of Hoechst
33342 binding than the E327C mutant. Unfortunately the
strong pH dependency of the protonation state and
fluorescence of Hoechst 33342 prevented us from determin-
ing the pH dependence of Hoechst 33342 binding.
Previously, we speculated that Asp142 and Glu327 both
interact with substrates [9]. However, the data presented
here show that the reduced activity of LmrP lacking Asp142
does not originate from a decreased substrate binding
affinity but from altered energetics of transport. The
observation that Asp142 and Glu327 are not strictly required
for substrate binding is in agreement with data obtained
from the crystal structures of QacR, a transcriptional
regulator of the qacA, the MDR transporter gene of
Staphylococcus aureus [33,34], and of AcrB, a drug
transporter of E. coli [35]. Both QacR and AcrB were
crystallized in the presence of various inducers and
substrates. Both proteins possess several aromatic and
acidic amino acids in the drug binding sites, subsets of
which interact with different substrates. Interestingly, bind-
ing of ethidium by AcrB does not involve carboxylic
residues [35], and QacR uses oxygen atoms of the peptide
backbone instead of acidic residues to neutralize the positive
charge of pentamidine [34]. Therefore, the presence of
charged residues in the membrane domain of transporters
does not seem to be a prerequisite of substrate binding but
may be critical for proton translocation.Previously, we have shown that upon interaction with
substrates, the membrane-embedded residues D142C and
E327C become more accessible to solvent [9]. This change
in solvent exposure may be related to the transfer of these
residues from a hydrophobic substrate binding site to a more
hydrophilic substrate translocation pathway. On the basis of
these findings, we propose for LmrP a transport mechanism
as depicted in Fig. 7. Deprotonation of Asp142 and Glu327
results in the inward-facing conformation of LmrP, at which
stage the protein can accept a substrate from the membrane
(I). The substrate binding triggers a structural change in
LmrP resulting in an outward-facing conformation with
Asp142 and Glu327 exposed to more hydrophilic environ-
ment (II). At this step the protonation of Asp142 and Glu327
occurs, which is linked to the release of the substrate to the
outside medium. Protonated LmrP (III) returns to the
inward-facing state (I) with concurrent release of protons
to the cytoplasm. The energetics of LmrP-mediated trans-
port suggests that the transporter utilizes two protons to
extrude one molecule of either ethidium or propidium. In
other words, the H+/substrate stoichiometry is invariant to
the charge of the substrate transported.References
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